India Diabetes Research Foundation and Dr. A. Ramachandran’s Diabetes Hospitals, Chennai, India.
Diabetes Care. 2010 Oct;33(10):2164-8. doi: 10.2337/dc09-1150. Epub 2010 Jun 2.
Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) have different pathophysiological abnormalities, and their combination may influence the effectiveness of the primary prevention tools. The hypothesis was tested in this analysis, which was done in a pooled sample of two Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2).
Researchers analyzed and followed up on the details of 845 of the 869 IGT subjects in the two studies for 3 years. Incidence of diabetes and reversal to normoglycemia (normal glucose tolerance [NGT]) were assessed in group 1 with baseline isolated IGT (iIGT) (n = 667) and in group 2 with IGT + IFG (n = 178). The proportion developing diabetes in the groups were analyzed in the control arm with standard advice (IDPP-1) (n = 125), lifestyle modification (LSM) (297 from both), metformin (n = 125, IDPP-1), and LSM + metformin (n = 121, IDPP-1) and LSM + pioglitazone (n = 298, IDPP-2). Cox regression analysis was used to assess the influence of IGT + IFG versus iIGT on the effectiveness of the interventions.
Group 2 had a higher proportion developing diabetes in 3 years (56.2 vs. 33.6% in group 1, P = 0.000) and a lower rate of reversal to NGT (18 vs. 32.1%, P = 0.000). Cox regression analysis showed that effectiveness of intervention was not different in the presence of fasting and postglucose glycemia after adjusting for confounding variables.
The effectiveness of primary prevention strategies appears to be similar in subjects with iIGT or with combined IGT + IFG. However, the possibility remains that a larger study might show that the effectiveness is lower in those with the combined abnormality.
糖耐量受损(IGT)和空腹血糖受损(IFG)具有不同的病理生理异常,它们的组合可能会影响初级预防工具的效果。本分析检验了这一假设,该分析是在两项印度糖尿病预防计划(IDPP-1 和 IDPP-2)的合并样本中进行的。
研究人员对两项研究中 869 名 IGT 受试者中的 845 名的详细信息进行了分析和随访,随访时间为 3 年。在第 1 组中,有 667 名基线孤立性 IGT(iIGT)的患者和第 2 组中 IGT+IFG(n=178)的患者评估了糖尿病的发病率和血糖正常(正常糖耐量[NGT])的逆转情况。在对照组中,用标准建议(IDPP-1)(n=125)、生活方式改变(LSM)(两组共 297 人)、二甲双胍(n=125,IDPP-1)和 LSM+二甲双胍(n=121,IDPP-1)和 LSM+吡格列酮(n=298,IDPP-2)分析了两组中出现糖尿病的比例。采用 Cox 回归分析评估 IGT+IFG 与 iIGT 对干预效果的影响。
第 2 组在 3 年内发生糖尿病的比例较高(56.2%比第 1 组的 33.6%,P=0.000),逆转至 NGT 的比例较低(18%比 32.1%,P=0.000)。Cox 回归分析显示,在调整混杂变量后,空腹和餐后血糖对干预效果没有影响。
在 iIGT 或 IGT+IFG 患者中,初级预防策略的效果似乎相似。然而,仍有可能表明,一项更大的研究可能表明,在同时存在这两种异常的患者中,其效果较低。